Scientific studies have examined the CJC-1295 Ipamorelin peptide for its potential role in modulating GH secretion. CJC-1295, classified as a growth hormone-releasing hormone (GHRH) analog, has been investigated for its effects on extending GH pulses in experimental models, while Ipamorelin functions as a GH secretagogue in research contexts. This blend is often employed in studies focusing on:

Product Specifications

• Composition: 10mg CJC-1295 (no DAC) + 10mg Ipamorelin per vial.
• Purity: ≥99% (confirmed via independent HPLC analysis for research consistency).
• Form: Lyophilized powder suitable for reconstitution with appropriate solvents (not provided).
• Molecular Weight: CJC-1295: approximately 3367.9 Da; Ipamorelin: approximately 711.9 Da.
• Storage: Maintain at -20°C for extended stability; store refrigerated post-reconstitution and utilize within recommended research timelines.
• Solubility: Compatible with sterile water or saline for experimental preparation.